Fig. 1From: Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantationRecurrence-free and overall survival of the entire cohort of patients receiving TDF or ETV therapy after LT for HBV-related HCC. TDF = tenofovir disoproxil fumarate; ETV = entecavir; LT = liver transplantation; HBV = hepatitis B virus; HCC = hepatocellular carcinoma. A. Comparison of Recurrence-free Survival in entire cohort. B. Comparison of Overall Survival in entire cohortBack to article page